Jerrold Henry Levy

Conference Blood · November 5, 2024 Background and Significance: Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) require anticoagulation to prevent hemostatic activation and circuit thrombosis. Unfract ... Full text Cite

DROXIDOPA OR ATOMOXETINE FOR REFRACTORY HYPOTENSION IN CARDIOTHORACIC SURGERY ICU PATIENTS

Conference CRITICAL CARE MEDICINE · January 2024 Link to item Cite

Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients

Conference Blood · November 2, 2023 Background and Significance: Patients following cardiac surgery often develop coagulopathic bleeding and associated poor outcomes. The development of coagulopathy is multifactorial, including anticoagulation, hemorrhage ... Full text Cite

MILRINONE DOSING CHARACTERISTICS AND ARRHYTHMIA ASSOCIATION AFTER CARDIAC SURGERY

Conference CRITICAL CARE MEDICINE · January 2023 Link to item Cite

Bleeding in Patients Receiving Inhaled Pulmonary Vasodilators for Heart Failure Operations

Conference CIRCULATION · November 16, 2021 Link to item Cite

Inhaled Selective Pulmonary Vasodilators for Adult Lung Transplantation

Conference JOURNAL OF HEART AND LUNG TRANSPLANTATION · April 2021 Link to item Cite

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies

Conference JOURNAL OF HEART AND LUNG TRANSPLANTATION · April 2021 Link to item Cite

Longitudinal Metabolic Profiling in Pregnancy of Women with and without Pregestational Diabetes Who Develop Preeclampsia.

Conference REPRODUCTIVE SCIENCES · March 2020 Link to item Cite

PREDICTIVE VALUE OF 4T′S AND HEP SCORE FOR HIT WITH MECHANICAL CIRCULATORY SUPPORT

Conference CRITICAL CARE MEDICINE · January 2020 Link to item Cite

Protocolized hemostatic factor use in major thoracic aortic surgery.

Conference J Cardiovasc Surg (Torino) · October 2019 Full text Link to item Cite

NON VITAMIN K ORAL ANTICOAGULANTS ARE NOT ASSOCIATED WITH INCREASED RISK OF PERIOPERATIVE BLEEDING IN PATIENTS UNDERGOING CARDIAC SURGERY

Conference Journal of the American College of Cardiology · March 2019 Full text Cite

IDARUCIZUMAB FOR REVERSAL OF THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY, OR INTERVENTIONS

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

HEALTH CARE RESOURCE UTILIZATION IN PATIENTS REQUIRING URGENT SURGICAL/INTERVENTIONAL MANAGEMENT WHILE TAKING DABIGATRAN: INTERIM RESULTS FROM THE RE-VERSE AD STUDY

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From REVERSE AD.

Conference STROKE · February 1, 2016 Link to item Cite

Prothrombin Complex Concentrates and Cardiac Surgery

Conference BLOOD · December 3, 2015 Link to item Cite

Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study

Conference EUROPEAN HEART JOURNAL · August 1, 2015 Link to item Cite

Abstract 4589: Association of genes, pathways, and haplogroups of the mitochondrial genome with the risk of colorectal cancer: The Multiethnic Cohort

Conference Cancer Research · August 1, 2015 AbstractThe mitochondrial genome encodes for the synthesis of 13 proteins that are essential for the oxidative phosphorylation (OXPHOS) system. Inherited variation in mitochondrial genes may influence cancer ... Full text Cite

Post Hoc Analysis of Desirudin Versus Enoxaparin for Thromboprophylaxis in High-Risk Patients Undergoing Elective Hip Replacement Surgery

Conference BLOOD · December 6, 2014 Link to item Cite

Identification and functional characterization of candidate topographic guidance molecules in the chick tectum

Conference International Journal of Developmental Neuroscience · December 2012 Full text Cite

INTEGRATED SAFETY ANALYSIS OF RECOMBINANT HUMAN ANTITHROMBIN ADMINISTRATION IN PATIENTS WITH HEPARIN RESISTANCE REQUIRING CARDIAC SURGERY AND CARDIOPULMONARY BYPASS

Conference CRITICAL CARE MEDICINE · December 2012 Link to item Cite

VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial

Conference BLOOD · November 18, 2011 Link to item Cite

USE OF THE SUBCUTANEOUS (SC) DIRECT THROMBIN INHIBITOR (DTI) DESIRUDIN (DES) IN PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA (HIT) REQUIRING VENOUS THROMBOEMBOLIC EVENT (VTE) PROPHYLAXIS

Conference CRITICAL CARE MEDICINE · December 2010 Link to item Cite

Can High-Quality Interventional Trials be Performed in Cardiac Surgery Patients With Excessive Bleeding Despite Conventional Blood Transfusion Therapy?

Conference CIRCULATION · November 23, 2010 Link to item Cite

Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis

Conference CIRCULATION · November 23, 2010 Link to item Cite

Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing-Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis

Conference BLOOD · November 19, 2010 Link to item Cite

Lack of Clinically Significant Interactions Between the Subcutaneously Administered Direct Thrombin Inhibitor Desirudin and Orally Administered Warfarin Upon the International Normalized Ratio

Conference BLOOD · November 20, 2009 Link to item Cite

Protamine inhibits conversion of prothrombin to thrombin

Conference SWISS MEDICAL WEEKLY · October 17, 2009 Link to item Cite

Evaluation of the REG1 Anticoagulant System Using Thrombelastography and Thrombin Generation Assay.

Conference Blood · November 16, 2007 AbstractBackground: The REG1 system (Regado Biosciences, Inc. Durham, NC) is a novel anticoagulant system which comprises RB006 (drug) and RB007 (antidote). The aptamer, RB006 selectively binds to FIXa and b ... Full text Cite